Mapping the effectiveness and risks of GLP-1 receptor agonists.
Xie Y, Choi T, Al-Aly Z.
Nat Med. 2025 Mar;31(3):951-962. doi: 10.1038/s41591-024-03412-w. Epub 2025 Jan 20.
Dementia in Diabetes: The Role of Hypoglycemia.
Husain KH, Sarhan SF, AlKhalifa HKAA, Buhasan A, Moin ASM, Butler AE.
Int J Mol Sci. 2023 Jun 7;24(12):9846. doi: 10.3390/ijms24129846.
Life of a Type 1 diabetic.
Kilbreath A.
Fam Syst Health. 2024 Dec;42(4):649-650. doi: 10.1037/fsh0000907. Epub 2024 Jul 25.
Insulin use: preventable errors.
Prescrire Editorial Staff.
Prescrire Int. 2014 Jan;23(145):14-7.
Envisioning the neuroprotective effect of Metformin in experimental epilepsy: A portrait of molecular crosstalk.
H S N, Paudel YN, K L K.
Life Sci. 2019 Sep 15;233:116686. doi: 10.1016/j.lfs.2019.116686. Epub 2019 Jul 23.
Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.
Frier BM.
Nat Rev Endocrinol. 2014 Dec;10(12):711-22. doi: 10.1038/nrendo.2014.170. Epub 2014 Oct 7.
Machine Learning Techniques for Hypoglycemia Prediction: Trends and Challenges.
Mujahid O, Contreras I, Vehi J.
Sensors (Basel). 2021 Jan 14;21(2):546. doi: 10.3390/s21020546.
Topiramate and type 2 diabetes: an old wine in a new bottle.
Khanna V, Arumugam S, Roy S, Mittra S, Bansal VS.
Expert Opin Ther Targets. 2008 Jan;12(1):81-90. doi: 10.1517/14728222.12.1.81.
Treatment of pilocarpine-induced epileptic seizures in adult male mice.
Abdelbasset WK, Jasim SA, Rudiansyah M, Huldani H, Margiana R, Jalil AT, Mohammad HJ, Ridha HS, Yasin G.
Braz J Biol. 2022 May 16;84:e260091. doi: 10.1590/1519-6984.260091. eCollection 2022.
Effect of insulin-induced hypoglycaemia on the central nervous system: evidence from experimental studies.
Jensen VF, Bøgh IB, Lykkesfeldt J.
J Neuroendocrinol. 2014 Mar;26(3):123-50. doi: 10.1111/jne.12133.
